Tools

LEADER 03528nam 2200625 i 4500

001 on1536126487;

005 20250915175153.0;

006 m o d f ;

007 cr bn||||a||||;

008 250915s2025 dcua ob f000 0 eng c;

024 8 a| 59-561q| (GPO jacket number);

035 a| (Sirsi) o1536126487;

035 a| (OCoLC)1536126487;

042 a| pcc;

043 a| n-us---a| n-cn---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:119-4;

088 a| Serial no. 119-4 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Combating existing and emerging illicit drug threats :b| hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Nineteenth Congress, first session, February 6, 2025.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2025.;

300 a| 1 online resource (vi, 237 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Associated bill citation(s): H.R. 27.;

500 a| "Serial no. 119-4.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Raymond Cullen, Family Advocate; Sheriff Michael Bouchard, Vice President, Government Affairs, Major County Sheriffs of America; Timothy W. Westlake, M.D., Emergency Physician, Oconomowoc Memorial Hospital, ProHealth Care Medical System; Regina M. LaBelle, Professor of Addiction Policy, Georgetown University Graduate School of Arts and Sciences; Deepa Camenga, M.D., Chair, Committee on Substance Use and Prevention, American Academy of Pediatrics.;

518 a| Date of hearing: 2025-02-06.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed Sept. 15, 2025).;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

651 0 a| United Statesx| Commercez| Canada.=| ^A191809;

650 0 a| Fentanylz| United States.=| ^A719975;

651 0 a| Canadax| Commercez| United States.=| ^A191808;

650 0 a| Economic sanctions, Americanz| Canada.=| ^A230900;

650 0 a| Tariffz| Canada.=| ^A110184;

650 0 a| Automobile industry and tradez| United States.=| ^A989986;

650 0 a| Drug trafficz| Canadian-American Border Region.=| ^A964547;

650 0 a| National securityz| United States.=| ^A273467;

650 7 a| Health.2| cgpa;

650 7 a| Commerce.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

856 40 u| https://purl.fdlp.gov/GPO/gpo2485787| 0;

856 4 z| Address at time of PURL creationu| https://www.govinfo.gov/content/pkg/CHRG-119hhrg59561/pdf/CHRG-119hhrg59561.pdf;

949 a| Click on web addressw| asish| joyner94;

994 a| C0b| GPO;

955 a| bca68 20250915b| 20250915;

922 a| BIBCONEWb| 20250915;

596 a| 1;

998 a| 6652578;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6652578-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 11/20/2025x| EDOCUMENTz| JERESOURCE;

Combating existing and emerging illicit drug threats : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Nineteenth Congress, first session, February 6, 2025.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2025.
Description	1 online resource (vi, 237 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo248578
Supplemental Content	Address at time of PURL creation
Subjects	Fentanyl--United States. Economic sanctions, American--Canada. Tariff--Canada. Automobile industry and trade--United States. Drug traffic--Canadian-American Border Region. National security--United States. United States--Commerce. --Canada. Canada--Commerce. --United States.

General note	Associated bill citation(s): H.R. 27.
General note	"Serial no. 119-4."
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Raymond Cullen, Family Advocate; Sheriff Michael Bouchard, Vice President, Government Affairs, Major County Sheriffs of America; Timothy W. Westlake, M.D., Emergency Physician, Oconomowoc Memorial Hospital, ProHealth Care Medical System; Regina M. LaBelle, Professor of Addiction Policy, Georgetown University Graduate School of Arts and Sciences; Deepa Camenga, M.D., Chair, Committee on Substance Use and Prevention, American Academy of Pediatrics.
Date/time/place of a event note	Date of hearing: 2025-02-06.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed Sept. 15, 2025).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Combating existing and emerging illicit drug threats. Washington : U.S. Government Publishing Office, 2025
Genre/form	Legislative hearings.
Standard identifier#	59-561 (GPO jacket number)
Technical rpt number	Serial no. 119-4 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:119-4

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Online Content https://purl.fdlp.gov/GPO/gpo248578 Address at time of PURL creation	✔ Available

Combating existing and emerging illicit drug threats : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Nineteenth Congress, first session, February 6, 2025.

Click here for more information about this title

Availability